Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)

被引:67
作者
Yang, JS
Kim, JJ
Hwang, D
Choo, AY
Dang, K
Maguire, H
Kudchodkar, S
Ramanathan, MP
Weiner, DB
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Viral Genomix, Philadelphia, PA USA
基金
美国国家卫生研究院;
关键词
D O I
10.1086/323395
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
West Nile virus (WNV) is a vectorborne pathogen that induces brain inflammation and death. Recently, confirmed cases of infection and deaths have occurred in the United States Mid-Atlantic region. In this study, a DNA vaccine encoding the WNV capsid protein was constructed, and the in vivo immune responses generated were investigated in DNA vaccine-immunized mice. Antigen-specific humoral and cellular immune responses were observed, including a potent induction of antigen-specific Th1 and cytotoxic, T lymphocyte responses. Strong induction of Th1-type immune responses included high levels of antigen-specific elaboration of the Th1-type cytokines interferon-gamma and interleukin-2 and beta -chemokines RANTES (regulated upon activation, normal T cell-expressed and secreted) and macrophage inflammatory protein-1 beta. Dramatic infiltration of CD4 and CD8 T cells and macrophages also was observed at the muscle injection site, These results support the potential utility of this method as a tool for developing immunization strategies for WNV and other emerging pathogens.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 23 条
[1]  
Agadjanyan MG, 1999, J IMMUNOL, V162, P3417
[2]   Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut [J].
Anderson, JF ;
Andreadis, TG ;
Vossbrinck, CR ;
Tirrell, S ;
Wakem, EM ;
French, RA ;
Garmendia, AE ;
Van Kruiningen, HJ .
SCIENCE, 1999, 286 (5448) :2331-2333
[3]  
AUSUBEL FM, 1999, SHORT PROTOCOLS MOL, V1
[4]   Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines [J].
Boyer, JD ;
Cohen, AD ;
Vogt, S ;
Schumann, K ;
Nath, B ;
Ahn, L ;
Lacy, K ;
Bagarazzi, ML ;
Higgins, TJ ;
Baine, Y ;
Ciccarelli, RB ;
Ginsberg, RS ;
MacGregor, RR ;
Weiner, DB .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :476-483
[5]   Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis [J].
Briese, T ;
Jia, XY ;
Huang, C ;
Grady, LJ ;
Lipkin, WI .
LANCET, 1999, 354 (9186) :1261-1262
[6]  
Chattergoon MA, 1998, J IMMUNOL, V160, P5707
[7]   Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis [J].
Chattergoon, MA ;
Kim, JJ ;
Yang, JS ;
Robinson, TM ;
Lee, DJ ;
Dentchev, T ;
Wilson, DM ;
Ayyavoo, V ;
Weiner, DB .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :974-979
[8]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[9]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511
[10]   Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells [J].
Jordan, I ;
Briese, T ;
Fischer, N ;
Lau, JYN ;
Lipkin, WI .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1214-1217